The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | The importance of diagnosing lung cancer early in young adults
Filiz Oezkan, MD, West German Cancer Center, Essen, Germany, highlights the differential survival rates of lung cancer across different age groups and value of early diagnosis in young adults. Whilst treatment strategies should be consistent across all age groups, CT and PET scans need to be more prevalent in the young population. Distant and brain metasteses are more commonly observed in younger patients upon diagnosis. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
